药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Potassium cation
Isopropamide
The risk or severity of Tachycardia and drowsiness can be increased when Isopropamide is combined with Cannabidiol.
Potassium cation
Solifenacin
The risk or severity of Tachycardia and drowsiness can be increased when Solifenacin is combined with Cannabidiol.
Potassium cation
Methylene blue
Cannabidiol may increase the serotonergic activities of Methylene blue.
Potassium cation
Diphenadione
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Diphenadione.
Potassium cation
Clorindione
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clorindione.
Potassium cation
Ethyl biscoumacetate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ethyl biscoumacetate.
Potassium cation
4-hydroxycoumarin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with 4-hydroxycoumarin.
Potassium cation
Tioclomarol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tioclomarol.
Potassium cation
Coumarin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Coumarin.
Potassium cation
Mianserin
The therapeutic efficacy of Mianserin can be decreased when used in combination with Cannabidiol.
Potassium cation
Naxitamab
The risk or severity of hypertension can be increased when Cannabidiol is combined with Naxitamab.
Potassium cation
Loxoprofen
The risk or severity of hypertension can be increased when Cannabidiol is combined with Loxoprofen.
Potassium cation
Selpercatinib
The risk or severity of hypertension can be increased when Cannabidiol is combined with Selpercatinib.
Potassium cation
Levosalbutamol
The risk or severity of hypertension can be increased when Cannabidiol is combined with Levosalbutamol.
Potassium cation
Tolfenamic acid
The risk or severity of hypertension can be increased when Cannabidiol is combined with Tolfenamic acid.
Potassium cation
Vilanterol
The risk or severity of hypertension can be increased when Cannabidiol is combined with Vilanterol.
Potassium cation
Zomepirac
The risk or severity of hypertension can be increased when Zomepirac is combined with Cannabidiol.
Potassium cation
Metamizole
The risk or severity of hypertension can be increased when Metamizole is combined with Cannabidiol.
Potassium cation
Nimesulide
The risk or severity of hypertension can be increased when Nimesulide is combined with Cannabidiol.
Potassium cation
Aceclofenac
The risk or severity of hypertension can be increased when Aceclofenac is combined with Cannabidiol.